Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study
Doctors may need to monitor patients to ensure they do not lose excessive weight
Incidences of other toxicities were comparable across the three treatment groups in DURATION-8 (exenatide plus dapagliflozin, exenatide alone, and dapagliflozin alone, respectively), including pancreatitis (1.3%, 0.4%, and 0%), volume depletion (1.3%, 0.4%, and 2.1%), gastrointestinal events (20.8%, 23.9%, and 16.3%), and genital infections (5.2%, 2.2%, and 7.7%) [36]
BioMetals 23 , 985996 (2010)
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
